Research output per year
Research output per year
Fingerprint
Dive into the research topics where Fabian Reich is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Fluctuation of Acquired Resistance Mutations and Re-Challenge with EGFR TKI in Metastatic NSCLC: A Case Report
Falk, M., Schatz, S., Reich, F. (Co-author), Schmidt, S., Galster, M. (Co-author), Tiemann, M., Ficker, J. (Co-author) & Brueckl, W. (Last author), Oct 2023, In: CURRENT ONCOLOGY. 30, 10, p. 8865-8871 7 p.Research output: Contribution to journal › Case report › peer-review
Open Access -
Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC)
Bruckl, N., Wirtz, R., Veltrup, E., Meyer, C., Zeitler, G., Wuerflein, D., Reich, F., Ficker, J. H., Eidt, S. & Bruckl, W., 2022, In: Oncology Research and Treatment. 45, SUPPL 3, p. 148-148Research output: Contribution to journal › published Abstract (Journal) › peer-review
-
Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung cancer (NSCLC) UICC stage IV
Brueckl, W. M. (First author), Reck, M., Rittmeyer, A., Kollmeier, J., Wesseler, C., Wiest, G. H., Christopoulos, P., Stenzinger, A., Tufman, A., Hoffknecht, P., Ulm, B., Reich, F. (Co-author), Ficker, J. H. (Co-author) & Laack, E., 2021, In: TRANSLATIONAL LUNG CANCER RESEARCH. 10, 7, p. 309-3105Research output: Contribution to journal › Original Article (Journal) › peer-review
28 Citations (Web of Science) -
Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV.
Brueckl, W. M. (First author), Reck, M., Rittmeyer, A., Kollmeier, J., Wesseler, C., Wiest, G. H., Christopoulos, P., Tufman, A., Hoffknecht, P., Ulm, B., Reich, F. (Co-author), Ficker, J. H. (Co-author) & Laack, E., 2020, In: CLINICAL MEDICINE INSIGHTS-ONCOLOGY. 14, p. 1179554920951358Research output: Contribution to journal › Original Article (Journal) › peer-review
24 Citations (Web of Science) -
3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling.
Sedding, D. G., Tröbs, M., Reich, F. (Co-author), Walker, G., Fink, L., Haberbosch, W., Rau, W., Tillmanns, H., Preissner, K. T., Bohle, R. M. & Langheinrich, A. C., 2009, In: CIRCULATION RESEARCH. 104, 10, p. 119-200Research output: Contribution to journal › Original Article (Journal) › peer-review
21 Citations (Web of Science)